Pong AW - Search Results

1

Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials.

Pong AW, Ross J, Tyrlikova I, Giermek AJ, Kohli MP, Khan YA, Salgado RD, Klein P. Pong AW, et al. Expert Opin Emerg Drugs. 2022 Mar;27(1):75-90. doi: 10.1080/14728214.2022.2059464. Epub 2022 Apr 1. Expert Opin Emerg Drugs. 2022. PMID: 35341431

2

High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.

Depositario-Cabacar DT, Peters JM, Pong AW, Roth J, Rotenberg A, Riviello JJ Jr, Takeoka M. Depositario-Cabacar DT, et al. Among authors: pong aw. Epilepsia. 2010 Jul;51(7):1319-22. doi: 10.1111/j.1528-1167.2010.02519.x. Epub 2010 Feb 12. Epilepsia. 2010. PMID: 20163437 Free article.

3

Genetic evaluation and counseling for epilepsy.

Pal DK, Pong AW, Chung WK. Pal DK, et al. Among authors: pong aw. Nat Rev Neurol. 2010 Aug;6(8):445-53. doi: 10.1038/nrneurol.2010.92. Epub 2010 Jul 20. Nat Rev Neurol. 2010. PMID: 20647993 Review.

4

Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist.

Pong AW, Pal DK, Chung WK. Pong AW, et al. Pediatr Neurol. 2011 May;44(5):317-27. doi: 10.1016/j.pediatrneurol.2011.01.017. Pediatr Neurol. 2011. PMID: 21481738 Review.

5

A novel mutation in the aristaless domain of the ARX gene leads to Ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females.

Ekşioğlu YZ, Pong AW, Takeoka M. Ekşioğlu YZ, et al. Among authors: pong aw. Epilepsia. 2011 May;52(5):984-92. doi: 10.1111/j.1528-1167.2011.02980.x. Epub 2011 Mar 22. Epilepsia. 2011. PMID: 21426321 Free article.

6

Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes.

Pong AW, Geary BR, Engelstad KM, Natarajan A, Yang H, De Vivo DC. Pong AW, et al. Epilepsia. 2012 Sep;53(9):1503-10. doi: 10.1111/j.1528-1167.2012.03592.x. Epub 2012 Jul 19. Epilepsia. 2012. PMID: 22812641 Free article.

7

Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.

Obeid M, Pong AW. Obeid M, et al. Among authors: pong aw. Epilepsy Res. 2010 Sep;91(1):101-5. doi: 10.1016/j.eplepsyres.2010.06.009. Epilepsy Res. 2010. PMID: 20663645

8

Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.

Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG. Carlile GW, et al. Mol Pharmacol. 2000 Jan;57(1):2-12. Mol Pharmacol. 2000. PMID: 10617673

9

Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase.

Chalmers-Redman RM, Fraser AD, Carlile GW, Pong A, Tatton WG. Chalmers-Redman RM, et al. Biochem Biophys Res Commun. 1999 Apr 13;257(2):440-7. doi: 10.1006/bbrc.1999.0487. Biochem Biophys Res Commun. 1999. PMID: 10198232

10

Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells.

Tatton WG, Chalmers-Redman RM, Ju WJ, Mammen M, Carlile GW, Pong AW, Tatton NA. Tatton WG, et al. Among authors: pong aw. J Pharmacol Exp Ther. 2002 May;301(2):753-64. doi: 10.1124/jpet.301.2.753. J Pharmacol Exp Ther. 2002. PMID: 11961082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters